Texas 2021 87th Regular

Texas Senate Bill SB917 Comm Sub / Bill

Filed 05/13/2021

                    By: Hughes, et al. S.B. No. 917
 (In the Senate - Filed March 2, 2021; March 11, 2021, read
 first time and referred to Committee on Health & Human Services;
 May 13, 2021, reported adversely, with favorable Committee
 Substitute by the following vote:  Yeas 5, Nays 4; May 13, 2021,
 sent to printer.)
Click here to see the committee vote
 COMMITTEE SUBSTITUTE FOR S.B. No. 917 By:  Perry


 A BILL TO BE ENTITLED
 AN ACT
 relating to advance directives or health care or treatment
 decisions made by or on behalf of patients.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  This Act may be cited as the Respecting Texas
 Patients' Right to Life Act of 2021.
 SECTION 2.  The purpose of this Act is to protect the right
 of patients and their families to decide whether and under what
 circumstances to choose or reject life-sustaining treatment. This
 Act amends the applicable provisions of the Advance Directives Act
 (Chapter 166, Health and Safety Code) to ensure that, when an
 attending physician is unwilling to respect a patient's advance
 directive or a patient's or family's decision to choose the
 treatment necessary to prevent the patient's death,
 life-sustaining medical treatment will be provided for 90 days
 after an ethics or medical committee's review so that the patient
 can be transferred to a health care provider willing to honor the
 directive or treatment decision.
 SECTION 3.  Section 166.045(c), Health and Safety Code, is
 amended to read as follows:
 (c)  If an attending physician refuses to comply with a
 directive or treatment decision to provide life-sustaining
 treatment to a patient [and does not wish to follow the procedure
 established under Section 166.046], life-sustaining treatment
 shall be provided to the patient for 90 days under the procedures
 prescribed by Section 166.046 so that[, but only until a reasonable
 opportunity has been afforded for the transfer of] the patient can
 be transferred to another physician or health care facility willing
 to comply with the directive or treatment decision.
 SECTION 4.  Sections 166.046(a), (b), (d), (e), and (e-1),
 Health and Safety Code, are amended to read as follows:
 (a)  If an attending physician refuses to honor a patient's
 advance directive or a health care or treatment decision made by or
 on behalf of a patient, other than a directive or decision to
 provide artificial nutrition and hydration to the patient, the
 physician's refusal shall be reviewed by an ethics or medical
 committee. The attending physician may not be a member of that
 committee. The patient shall be given life-sustaining treatment
 during the review.
 (b)  The patient or the person responsible for the health
 care decisions of the individual who has made the decision
 regarding the directive or treatment decision:
 (1)  may be given a written description of the ethics or
 medical committee review process and any other policies and
 procedures related to this section adopted by the health care
 facility;
 (2)  shall be informed of the committee review process
 not less than 48 hours before the meeting called to discuss the
 patient's directive, unless the time period is waived by mutual
 agreement;
 (3)  at the time of being so informed, shall be
 provided:
 (A)  a copy of the appropriate statement set forth
 in Section 166.052; and
 (B)  a copy of the registry list of health care
 providers and referral groups that have volunteered their readiness
 to consider accepting transfer or to assist in locating a provider
 willing to accept transfer that is posted on the website maintained
 by the department under Section 166.053; and
 (4)  is entitled to:
 (A)  attend the meeting;
 (B)  receive a written explanation of the
 recommendations made [decision reached] during the review process;
 (C)  receive a copy of the portion of the
 patient's medical record related to the treatment received by the
 patient in the facility for the lesser of:
 (i)  the period of the patient's current
 admission to the facility; or
 (ii)  the preceding 30 calendar days; and
 (D)  receive a copy of all of the patient's
 reasonably available diagnostic results and reports related to the
 medical record provided under Paragraph (C).
 (d)  If the attending physician, the patient, or the person
 responsible for the health care decisions of the individual does
 not agree with the recommendations made [decision reached] during
 the review process under Subsection (b), the physician shall make a
 reasonable effort to transfer the patient to a physician who is
 willing to comply with the directive. If the patient is a patient in
 a health care facility, the facility's personnel shall assist the
 physician in arranging the patient's transfer to:
 (1)  another physician;
 (2)  an alternative care setting within that facility;
 or
 (3)  another facility.
 (e)  If the patient or the person responsible for the health
 care decisions of the patient is requesting life-sustaining
 treatment that the attending physician [has decided] and the ethics
 or medical committee consider [has affirmed is] medically
 inappropriate treatment, the patient shall be given available
 life-sustaining treatment pending transfer under Subsection (d).
 This subsection does not authorize withholding or withdrawing pain
 management medication, medical procedures necessary to provide
 comfort, or any other health care provided to alleviate a patient's
 pain.  [The patient is responsible for any costs incurred in
 transferring the patient to another facility.]  The attending
 physician, any other physician responsible for the care of the
 patient, and the health care facility are not obligated to provide
 life-sustaining treatment after the 90th [10th] day after both the
 written recommendation [decision] and the patient's medical record
 required under Subsection (b) are provided to the patient or the
 person responsible for the health care decisions of the patient
 unless ordered to do so under Subsection (g), except that
 artificially administered nutrition and hydration must be provided
 unless, based on reasonable medical judgment, providing
 artificially administered nutrition and hydration would:
 (1)  hasten the patient's death;
 (2)  be medically contraindicated such that the
 provision of the treatment seriously exacerbates life-threatening
 medical problems not outweighed by the benefit of the provision of
 the treatment;
 (3)  result in substantial irremediable physical pain
 not outweighed by the benefit of the provision of the treatment;
 (4)  be medically ineffective in prolonging life; or
 (5)  be contrary to the patient's or surrogate's
 clearly documented desire not to receive artificially administered
 nutrition or hydration.
 (e-1)  If during a previous admission to a facility a
 patient's attending physician and the review process under
 Subsection (b) have determined that life-sustaining treatment is
 inappropriate, and the patient is readmitted to the same facility
 within six months from the date of the recommendations made
 [decision reached] during the review process conducted upon the
 previous admission, Subsections (b) through (e) need not be
 followed if the patient's attending physician and a consulting
 physician who is a member of the ethics or medical committee of the
 facility document on the patient's readmission that the patient's
 condition either has not improved or has deteriorated since the
 review process was conducted.
 SECTION 5.  Section 166.051, Health and Safety Code, is
 amended to read as follows:
 Sec. 166.051.  LEGAL RIGHT OR RESPONSIBILITY NOT AFFECTED.
 This subchapter does not impair or supersede any legal right or
 responsibility a person may have to effect the withholding or
 withdrawal of life-sustaining treatment in a lawful manner,
 provided that if an attending physician or health care facility is
 unwilling to honor a patient's advance directive or a treatment
 decision to provide life-sustaining treatment, life-sustaining
 treatment must [is required to] be provided to the patient in
 accordance with this chapter[, but only until a reasonable
 opportunity has been afforded for transfer of the patient to
 another physician or health care facility willing to comply with
 the advance directive or treatment decision].
 SECTION 6.  Section 166.052(a), Health and Safety Code, is
 amended to read as follows:
 (a)  In cases in which the attending physician refuses to
 honor an advance directive or health care or treatment decision
 requesting the provision of life-sustaining treatment, the
 statement required by Section 166.046(b)(3)(A) shall be in
 substantially the following form:
 When There Is A Disagreement About Medical Treatment: The Physician
 Recommends Against Certain Life-Sustaining Treatment That You Wish
 To Continue
 You have been given this information because you have
 requested life-sustaining treatment* for yourself as the patient or
 on behalf of the patient, as applicable, which the attending
 physician believes is not medically appropriate. This information
 is being provided to help you understand state law, your rights, and
 the resources available to you in such circumstances. It outlines
 the process for resolving disagreements about treatment among
 patients, families, and physicians. It is based upon Section
 166.046 of the Texas Advance Directives Act, codified in Chapter
 166, Texas Health and Safety Code.
 When an attending physician refuses to comply with an advance
 directive or other request for life-sustaining treatment because of
 the physician's judgment that the treatment would be medically
 inappropriate, the case will be reviewed by an ethics or medical
 committee. Life-sustaining treatment will be provided through the
 review.
 You will receive notification of this review at least 48
 hours before a meeting of the committee related to your case. You
 are entitled to attend the meeting. With your agreement, the
 meeting may be held sooner than 48 hours, if possible.
 You are entitled to receive a written explanation of the
 recommendations made [decision reached] during the review process.
 If after this review process both the attending physician and
 the ethics or medical committee conclude that life-sustaining
 treatment is medically inappropriate and yet you continue to
 request such treatment, then the following procedure will occur:
 1.  The physician, with the help of the health care facility,
 will assist you in trying to find a physician and facility willing
 to provide the requested treatment.
 2.  You are being given a list of health care providers,
 licensed physicians, health care facilities, and referral groups
 that have volunteered their readiness to consider accepting
 transfer, or to assist in locating a provider willing to accept
 transfer, maintained by the Department of State Health Services.
 You may wish to contact providers, facilities, or referral groups
 on the list or others of your choice to get help in arranging a
 transfer.
 3.  The patient will continue to be given life-sustaining
 treatment until the patient can be transferred to a willing
 provider for up to 90 [10] days from the time you were given both the
 committee's written decision that life-sustaining treatment is not
 appropriate and the patient's medical record. The patient will
 continue to be given after the 90-day [10-day] period treatment to
 enhance pain management and reduce suffering, including
 artificially administered nutrition and hydration, unless, based
 on reasonable medical judgment, providing artificially
 administered nutrition and hydration would hasten the patient's
 death, be medically contraindicated such that the provision of the
 treatment seriously exacerbates life-threatening medical problems
 not outweighed by the benefit of the provision of the treatment,
 result in substantial irremediable physical pain not outweighed by
 the benefit of the provision of the treatment, be medically
 ineffective in prolonging life, or be contrary to the patient's or
 surrogate's clearly documented desires.
 4.  [If a transfer can be arranged, the patient will be
 responsible for the costs of the transfer.
 [5.]  If a provider cannot be found willing to give the
 requested treatment within 90 [10] days, life-sustaining treatment
 may be withdrawn unless a court of law has granted an extension.
 5. [6.]  You may ask the appropriate district or county court
 to extend the 90-day [10-day] period if the court finds that there
 is a reasonable expectation that you may find a physician or health
 care facility willing to provide life-sustaining treatment if the
 extension is granted. Patient medical records will be provided to
 the patient or surrogate in accordance with Section 241.154, Texas
 Health and Safety Code.
 *"Life-sustaining treatment" means treatment that, based on
 reasonable medical judgment, sustains the life of a patient and
 without which the patient will die. The term includes both
 life-sustaining medications and artificial life support, such as
 mechanical breathing machines, kidney dialysis treatment, and
 artificially administered nutrition and hydration. The term does
 not include the administration of pain management medication or the
 performance of a medical procedure considered to be necessary to
 provide comfort care, or any other medical care provided to
 alleviate a patient's pain.
 SECTION 7.  The changes in law made by this Act apply only to
 a health care or treatment decision made on or after the effective
 date of this Act.
 SECTION 8.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2021.
 * * * * *